PlainRecalls
FDA Drug Moderate Class II Terminated

Temozolomide Capsules, 100 mg, packaged in a) 5-count bottle (NDC 67877-539-07), b) 14-count bottle (NDC 67877-539-14), Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.

Reported: July 31, 2019 Initiated: July 16, 2019 #D-1510-2019

Product Description

Temozolomide Capsules, 100 mg, packaged in a) 5-count bottle (NDC 67877-539-07), b) 14-count bottle (NDC 67877-539-14), Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.

Reason for Recall

CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.

Details

Units Affected
a) 13752 bottles; b) 15696 bottles
Distribution
Nationwide in the USA.
Location
Cerkezkoy, N/A

Frequently Asked Questions

What product was recalled?
Temozolomide Capsules, 100 mg, packaged in a) 5-count bottle (NDC 67877-539-07), b) 14-count bottle (NDC 67877-539-14), Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.. Recalled by Deva Holding AS - Cerkezkoy Subesi. Units affected: a) 13752 bottles; b) 15696 bottles.
Why was this product recalled?
CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 31, 2019. Severity: Moderate. Recall number: D-1510-2019.